ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
Afucosylation can enable more precise assessment of allergic sensitization
Afucosylation can enable more precise assessment of allergic sensitization
IDEX Health & Science launches Manifold-in-a-Week Rapid Response Program that shortens development time of fluidics design
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
Niguarda Hospital case study now available
Top tips to optimize your analyses
The field of infectious diseases faces more complex and demanding challenges than every before
Vitrification provides excellent survivability of embryos and oocytes through the freezing process
Clinical Scientist, Lewis Couchman, explains how advances in mass spectrometry workflow automation are improving results at a leading London Pathology Department
A selection of interesting clinical diagnostic application articles
Company aims to help accelerate progress toward a vaccine or treatment for this global health threat
First test from a commercial lab to receive emergency use authorization for testing patients in the United States, including Puerto Rico, for Zika infection
A look at some of the newest generation ‘load and go’ molecular microbiology analyzers
Dr. Melina Schuh has been awarded the BINDER Innovation Prize for her research into the development of fertile egg cells in mammals
The epoc® Blood Analysis System provides the fast and accurate results that clinicians need to make accelerated treatment decisions
Exhibitor highlights from ESCMID’s annual congress in Amsterdam
Life science companies combine expertise to enhance transcriptome research
Findings from Sheffield Teaching Hospitals NHS Trust
ImageXpress and MetaXpress High-Content Toolset enables breakthrough Three-Dimensional assay development and Screening Workflow for cellular research
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis